Ad is loading...
AAMTX vs FAJTX
AAMTX vs FAJTX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
AAMTX vs. FAJTX commentary
Feb 25, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAMTX is a Hold and FAJTX is a Hold.
FUNDAMENTALS
Fundamentals
AAMTX (25.3B) and FAJTX (25.3B) have equal amount of cash in the bank . AAMTX (1.09) and FAJTX (1.07) have matching dividends . AAMTX was incepted earlier than FAJTX: AAMTX (15 years) vs FAJTX (11 years). AAMTX (1.00) and FAJTX (1.00) have comparable annual turnover. AAMTX (250) and FAJTX (250) have matching initial minimum investment requirements. AAMTX (10.72) and FAJTX (10.70) have marching annual gain over last year. AAMTX (40.62) and FAJTX (40.34) have equivalent 5 years return.
| AAMTX | FAJTX | AAMTX / FAJTX | |
| Total Expense Ratio | N/A | N/A | - |
| Annual Report Gross Expense Ratio | N/A | N/A | - |
| Fund Existence | 15 years | 11 years | - |
| Gain YTD | 2.797 | 2.779 | 101% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 250 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 25.3B | 25.3B | 100% |
| Annual Yield % from dividends | 1.09 | 1.07 | 101% |
| Returns for 1 year | 10.72 | 10.70 | 100% |
| Returns for 3 years | 14.13 | 14.00 | 101% |
| Returns for 5 years | 40.62 | 40.34 | 101% |
| Returns for 10 years | 71.36 | 70.19 | 102% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AGGNX | 14.74 | N/A | N/A |
| American Century Global Gold I | |||
| LOGSX | 21.00 | N/A | N/A |
| Live Oak Health Sciences | |||
| USLYX | 70.09 | N/A | N/A |
| JHancock U.S. Global Leaders Growth R2 | |||
| BGCJX | 14.84 | -0.12 | -0.80% |
| Baillie Gifford EAFE Plus All Cap 3 | |||
| MLAIX | 12.00 | -0.11 | -0.91% |
| NYLI Winslow Large Cap Growth Class I | |||